Effector T cell differentiation: are master regulators of effector T cells still the masters?

Current Opinion in Immunology
Chao WangVijay K Kuchroo

Abstract

Effector CD4 T cell lineages have been implicated as potent inducers of autoimmune diseases. Tbet, Gata3 and Rorgt are master transcriptional regulators of Th1, Th2 and Th17 lineages respectively and promote the distinct expression of signature cytokines. Significant progress has been made in understanding the transcriptional network that drives CD4 T cell differentiation, revealing novel points of regulation mediated by transcription factors, cell surface receptors, cytokines and chemokines. Epigenetic modifications and metabolic mediators define the transcriptional landscape in which master transcription factors operate and collaborate with a network of transcriptional modifiers to guide lineage specification, plasticity and function.

References

Mar 1, 1993·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·M Bental, C Deutsch
Apr 19, 2006·Immunity·Gap Ryol LeeRichard A Flavell
Dec 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Anna Morena D'AliseDiane Mathis
Mar 31, 2009·Current Opinion in Immunology·Liang Zhou, Dan R Littman
Jan 27, 2011·The Journal of Clinical Investigation·Guoliang CuiYing Qin Zang
Jun 6, 2012·The Journal of Biological Chemistry·Rajan M ThomasAndrew D Wells
Sep 11, 2012·Nature Immunology·Youjin LeeVijay K Kuchroo
Oct 2, 2012·Cell·Maria CiofaniDan R Littman
Jan 10, 2013·Annual Review of Immunology·Nancie J MacIverJeffrey C Rathmell
Jan 15, 2014·Nature Reviews. Rheumatology·Bruce C Richardson, Dipak R Patel
Feb 18, 2015·Nature·Golnaz VahediJohn J O'Shea
May 15, 2015·Science Translational Medicine·Yonghao CaoDavid A Hafler
Jul 15, 2015·Clinics and Research in Hepatology and Gastroenterology·G F Mells, G M Hirschfield

❮ Previous
Next ❯

Citations

Feb 3, 2016·Nature Reviews. Immunology·Donna L FarberRolf M Zinkernagel
Dec 23, 2015·The Journal of Clinical Investigation·Charlotte E EganDavid J Hackam
May 12, 2016·Annual Review of Immunology·Federica Sallusto
Jul 23, 2016·Frontiers in Immunology·Agnieszka M KabatKevin J Maloy
Nov 1, 2016·Brain : a Journal of Neurology·Konstantina PsachouliaJeffrey K Huang
Nov 20, 2016·European Journal of Immunology·Svenja SteinfelderSusanne Hartmann
Mar 9, 2017·European Journal of Immunology·Kathrin KlarClarissa Prazeres da Costa
Jan 22, 2017·Allergy·C H Flayer, A Haczku
Nov 29, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Matthew A KunickiMaria-Grazia Roncarolo
Aug 18, 2018·Journal of Leukocyte Biology·Lena MüllerWilfried Ellmeier
Apr 7, 2020·Nature Reviews. Cancer·Danilo FioreGiorgio Inghirami
Aug 27, 2017·Seminars in Immunopathology·Justin KillickAnne L Astier
Jun 16, 2017·Epigenomics·Thea van den BoschFrank J Dekker
Jun 29, 2018·Current Hematologic Malignancy Reports·Waseem LoneJaveed Iqbal
Jun 27, 2017·F1000Research·Dieter KabelitzOttmar Janssen
Mar 2, 2019·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Shivaprasad H Venkatesha, Kamal D Moudgil
Oct 11, 2017·Nature Communications·Sakshi MalikAmit Awasthi
Jan 10, 2021·Development·Wendy M ReevesMichael T Veeman
Jun 7, 2018·Cell Metabolism·Francesca CignarellaLaura Piccio

❮ Previous
Next ❯

Related Concepts

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cellular Immunometabolism

Immunometabolism involves not only the way metabolites are digested by the immune system, but the way in which they can alter the pathway of the immune system. These responses occur in day-to-day healthy cell functioning, but can result in diseases, such as autoimmune disorders. Discover the latest research on cellular immunometabolism here.

Related Papers

Briefings in Functional Genomics
Catherine M Evans, Richard G Jenner
Current Biology : CB
Douglas S Robinson, Clare M Lloyd
Current Opinion in Immunology
Derk AmsenR A Flavell
© 2021 Meta ULC. All rights reserved